|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1038067989 |
003 |
OCoLC |
005 |
20231120010257.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
180531s2018 enk ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d EBLCP
|d OPELS
|d YDX
|d MERER
|d OCLCF
|d OCLCQ
|d OTZ
|d NLE
|d UKMGB
|d U3W
|d LVT
|d D6H
|d OCLCA
|d OCLCQ
|d S2H
|d OCLCO
|d UX1
|d VT2
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d CASUM
|d OCL
|d OCLCO
|
066 |
|
|
|c (S
|
015 |
|
|
|a GBB8D5296
|2 bnb
|
016 |
7 |
|
|a 018887374
|2 Uk
|
019 |
|
|
|a 1038477129
|a 1235838677
|
020 |
|
|
|a 9780128120088
|q (electronic bk.)
|
020 |
|
|
|a 0128120088
|q (electronic bk.)
|
020 |
|
|
|a 9780128120194
|q (electronic bk.)
|
020 |
|
|
|a 0128120193
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)1038067989
|z (OCoLC)1038477129
|z (OCoLC)1235838677
|
050 |
|
4 |
|a RC662
|b .N88 2018eb
|
060 |
|
4 |
|a 2019 D-752
|
060 |
|
4 |
|a WK 810
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.4/620654
|2 23
|
245 |
0 |
0 |
|a Nutritional and therapeutic interventions for diabetes and metabolic syndrome /
|c edited by Debasis Bagchi, University of Houston College of Pharmacy, Houston, TX, United States, Cepham Research Center, Piscataway, NJ, United States, Sreejayan Nair, University of Wyoming, School of Pharmacy, Laramie, WY, United States.
|
250 |
|
|
|a Second edition.
|
264 |
|
1 |
|a London :
|b Academic Press, an imprint of Elsevier,
|c 2018.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed June 6, 2018).
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|6 880-01
|a Front Cover; NUTRITIONAL AND THERAPEUTIC INTERVENTIONS FOR DIABETES AND METABOLIC SYNDROME; NUTRITIONAL AND THERAPEUTIC INTERVENTIONS FOR DIABETES AND METABOLIC SYNDROME; Copyright; Dedication; Contents; Preface; References; I -- EPIDEMIOLOGY AND OVERVIEW; 1 -- Type 1 Diabetes Mellitus: An Overview; INTRODUCTION; DEFINITION; EPIDEMIOLOGY; PATHOPHYSIOLOGY; DIAGNOSIS; CLINICAL PRESENTATION; MANAGEMENT; COMORBIDITIES; COMPLICATIONS; PREVENTION AND INTERVENTION TRIALS; References; Further Reading; 2 -- Prediabetes: Prevalence, Pathogenesis, and Recognition of Enhanced Risk; BACKGROUND; PREVALENCE
|
505 |
8 |
|
|a MethodsStudy Sample; Sample Methods; Diagnosis of Prediabetes; Sample Description; Statistical Analysis; RESULTS; Epidemiology of Prediabetes; United States (1999-2006: NHANES Study); Australia (2002: ADOL Study); Europe (1999: DECODE Study); Hong Kong (1998); Mauritius (1999); Pima Indians in the United States (2000); Sweden (1998); United States (1997); PATHOGENESIS; Diagnosis; Pathophysiology; Adiposity Influences Prediabetes; Prediabetes Alters Serum Lipoprotein Patterns, Glycemia, and Resting Blood Pressure; RECOGNITION OF ENHANCED RISK; MEANS FOR CARDIOMETABOLIC RISK FACTORS; DISCUSSION
|
505 |
8 |
|
|a CONCLUSIONReferences; 3 -- Targeting Prediabetes to Preempt Diabetes; INTRODUCTION; GLOBAL BURDEN OF DIABETES AND PREDIABETES; Epicenters of Diabetes and Prediabetes; CONTRIBUTING FACTORS; Obesity; Diet and Nutrition; Social Habits; Physical Inactivity; PREVENTION AND TREATMENT OF DIABETES; Scope and Challenges of Diabetes Prevention Research; CONCLUSION; References; 4 -- Obesity and Type 2 Diabetes in Youths: New Challenges to Overcome; OBESITY: THE 21ST CENTURY EPIDEMIC; METABOLIC COMPLICATIONS OF OBESITY IN CHILDREN AND ADOLESCENTS
|
505 |
8 |
|
|a PESTICIDESDiabetes Cross-Sectional and Longitudinal Studies; Obesity Studies; BISPHENOL A AND PHTHALATES; Diabetes Cross-Sectional and Longitudinal Studies; Obesity Studies; AIR POLLUTION; Diabetes Cross-Sectional and Longitudinal Studies; Obesity Studies; TOXIC HEAVY METALS; Diabetes Cross-Sectional and Longitudinal Studies; Obesity Studies; SUMMARY AND FUTURE RESEARCH; References; 6 -- An Overview of the Roles of the Gut Microbiome in Obesity and Diabetes; BACKGROUND; Obesity; Type 2 Diabetes; The Gut Microbiome; MECHANISMS BY WHICH THE GUT MICROBIOME CAN INFLUENCE METABOLISM AND WEIGHT GAIN
|
520 |
|
|
|a Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome, Second Edition, provides an overview of the current diabetes epidemic, outlines the consequences of this crisis, and lays out strategies to forestall and prevent diabetes, obesity and other intricate issues of metabolic syndrome. Contributing experts provide up-to-date global approaches to the critical consequences of metabolic syndrome and make the book an important reference for those working with the treatment, evaluation or public health planning for the effects of metabolic syndrome and diabetes. Completely revised with 15 new chapters, the book includes coverage of the roles of gut microbiome in obesity and diabetes, macrovascular and microvascular complications, diabetes, metabolic syndrome and kidney disease, aspects of diabetic cardiomyopathy, diabetes, Alzheimer's and neurodegenerative diseases, roles of SGLT2 inhibitors in the treatment of type 2 diabetes, novel biomarkers in diabetes, roles of Trigonella foenum-graecumseed extract in type 2 diabetes, beneficial effects of chromium (III) and vanadium supplements in diabetes, prevention of type 1 diabetes, novel drugs in the therapeutic intervention of type 2 diabetes, eHealth and mobile apps for self-management, artificial pancreatic transplantation, non-invasive glucose monitoring, and the app for glucose regulation.
|
650 |
|
0 |
|a Diabetes
|x Nutritional aspects.
|
650 |
|
0 |
|a Diabetes
|x Treatment.
|
650 |
|
0 |
|a Metabolic syndrome
|x Nutritional aspects.
|
650 |
|
0 |
|a Metabolic syndrome
|x Treatment.
|
650 |
|
0 |
|a Diabetes.
|
650 |
|
0 |
|a Metabolic syndrome.
|
650 |
1 |
2 |
|a Diabetes Mellitus
|0 (DNLM)D003920
|
650 |
2 |
2 |
|a Diabetes Mellitus
|x diet therapy
|0 (DNLM)D003920Q000178
|
650 |
2 |
2 |
|a Metabolic Syndrome
|0 (DNLM)D024821
|
650 |
|
6 |
|a Diab�ete
|x Aspect nutritionnel.
|0 (CaQQLa)201-0066196
|
650 |
|
6 |
|a Syndrome m�etabolique
|0 (CaQQLa)201-0423716
|x Aspect nutritionnel.
|0 (CaQQLa)201-0377452
|
650 |
|
6 |
|a Syndrome m�etabolique
|0 (CaQQLa)201-0423716
|x Traitement.
|0 (CaQQLa)201-0377521
|
650 |
|
6 |
|a Diab�ete.
|0 (CaQQLa)201-0010252
|
650 |
|
6 |
|a Syndrome m�etabolique.
|0 (CaQQLa)201-0423716
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Metabolic syndrome
|2 fast
|0 (OCoLC)fst01738050
|
650 |
|
7 |
|a Diabetes
|2 fast
|0 (OCoLC)fst00892147
|
650 |
|
7 |
|a Diabetes
|x Nutritional aspects
|2 fast
|0 (OCoLC)fst00892176
|
650 |
|
7 |
|a Diabetes
|x Treatment
|2 fast
|0 (OCoLC)fst00892199
|
655 |
|
4 |
|a Internet Resources.
|
700 |
1 |
|
|a Bagchi, Debasis,
|d 1954-
|e editor.
|
700 |
1 |
|
|a Nair, Sreejayan,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Nutritional and therapeutic interventions for diabetes and metabolic syndrome.
|b Second edition.
|d London : Academic Press, an imprint of Elsevier, 2018
|z 0128120193
|z 9780128120194
|w (OCoLC)1011519170
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128120194
|z Texto completo
|
880 |
8 |
|
|6 505-01/(S
|a TYPE 2 DIABETES IN CHILDREN AND ADOLESCENTS: A NEW FRIGHTENING EPIDEMICPATHOGENESIS OF TYPE 2 DIABETES IN OBESE CHILDREN AND ADOLESCENTS; ROLE OF ECTOPIC FAT DEPOSITION IN THE PATHOGENESIS OF INSULIN RESISTANCE; THE Β-CELL IN THE STORM OF INSULIN RESISTANCE; THERAPY OF TYPE 2 DIABETES IN YOUTHS; CONCLUSIONS AND FUTURE PERSPECTIVES; References; Further Reading; 5 -- Roles of Environmental Pollution and Pesticides in Diabetes and Obesity: The Epidemiological Evidence; INTRODUCTION; DIOXINS, FURANS, AND POLYCHLORINATED BIPHENYLS; Diabetes Cross-Sectional and Longitudinal Studies; Obesity Studies
|